Clinical Advisors

James G. Krueger, M.D., Ph.D.

Dr. Krueger serves as Head of Laboratory of Investigative Dermatology and Professor in Clinical Investigation and Dermatology at Rockefeller University. Dr. Krueger is the D. Martin Carter Professor in Clinical Investigation and Head of the Laboratory of Investigative Dermatology at Rockefeller University. Dr. Krueger earned his bachelor’s degree from Princeton University and a Ph.D. in virology and cell biology from the Rockefeller University. He received an M.D. from Cornell University Medical College, where he also completed an internship in internal medicine and residency in dermatology. Dr. Krueger is certified by the American Board of Dermatology.

Emma Guttman-Yassky, M.D., Ph.D.

Dr. Guttman is an Associate Professor of Dermatology & Immunology and Director of the Center for Excellence in Eczema and the Occupational/Contact Dermatitis Clinic and the Director of the Laboratory of Inflammatory Skin Diseases in the Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York. Dr. Guttman earned her M.D. degree from Sackler School of Medicine at the Tel-Aviv University, and a Ph.D. degree from the Bar-Ilan University Ramat-Gan, Israel and completed her dermatology residencies at the Dermatology Department at the Rambam Medical Center/Technion Institute in Haifa and the Weill-Cornell Medical College, in New York.

Alexa Kimball, M.D., M.P.H.

Alexa B. Kimball, MD, MPH is a Professor of Dermatology at Harvard Medical School and CEO and President of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center, a large academic multi-specialty 501(c)3 corporation based in Boston, Massachusetts. Dr. Kimball also co-chairs the Beth Israel Lahey Health Performance Network Board and is on the Board of Trustees of Beth Israel Lahey Health. She has published over 300 papers and conducted over 150 clinical trials with an emphasis on inflammatory skin diseases. Based on this work, Dr. Kimball has been awarded the American Skin Association Research Award for Health Policy and Medical Education, Mentor of the Year from the Women’s Dermatologic Society and Outstanding Physician-Clinician Award from the National Psoriasis Foundation. She has served on the non-profit Boards of the Society for Investigative Dermatology, the Massachusetts Foundation for the Humanities and Public Policy, and the Hidradenitis Suppurativa Foundation and is the recent past President of the International Psoriasis Council.

Willam Sandborn, M.D.

Dr. Sandborn serves as the Chief of Division of Gastroenterology at University of California San Diego Inflammatory Bowel Disease Center and Professor of Clinical Medicine. He served as Chief of the Division of Gastroenterology for the UC San Diego Health System. Dr. Sandborn has served as head of the Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota and has been has been Professor of Clinical Medicine at University of California San Diego, La Jolla since January 2011. Dr. Sandborn has also served as on the faculty of the Mayo Clinic as Director of the IBD Center. Dr. Sandborn received his medical degree in internal medicine from Loma Linda University in Loma Linda California.

Sander van Deventer, M.D., Ph.D.

Dr. van Deventer is currently an Operating Partner at Forbion Capital Partners. In addition, Sander is a professor in Translational Gastroenterology at the University of Leiden. In 1995, he became director of the laboratory for Experimental Internal Medicine at the Academic Medical Centre in Amsterdam. From 2001 until 2004, he chaired the Department of Gastroenterology and Hepatology at the Academic Medical Centre in Amsterdam.